0.4886
前日終値:
$0.489
開ける:
$0.567
24時間の取引高:
1.62M
Relative Volume:
6.22
時価総額:
$10.72M
収益:
$4.03M
当期純損益:
$24.32M
株価収益率:
-0.1136
EPS:
-4.3008
ネットキャッシュフロー:
$-45.76M
1週間 パフォーマンス:
+12.19%
1か月 パフォーマンス:
+15.39%
6か月 パフォーマンス:
-28.15%
1年 パフォーマンス:
-58.24%
Pavmed Inc Stock (PAVM) Company Profile
PAVM を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
PAVM
Pavmed Inc
|
0.4886 | 10.73M | 4.03M | 24.32M | -45.76M | -4.3008 |
![]()
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-03-30 | 開始されました | Cantor Fitzgerald | Overweight |
2020-11-05 | 開始されました | Ascendiant Capital Markets | Buy |
2018-06-28 | 開始されました | Maxim Group | Buy |
Pavmed Inc (PAVM) 最新ニュース
Using R and stats models for PAVmed Inc. forecastingQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
PAVmed (PAVM) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Statistical indicators supporting PAVmed Inc.’s strengthJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
Will PAVmed Inc. rebound enough to break evenDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
Volume spikes in PAVmed Inc. stock – what they meanWeekly Trend Summary & Fast Entry High Yield Stock Tips - newser.com
What high frequency data says about PAVmed Inc.2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Analyzing PAVmed Inc. with multi timeframe chartsQuarterly Earnings Report & Entry and Exit Point Strategies - newser.com
PAVmed subsidiary Veris Health launches cancer care platform at OSU center - Investing.com Canada
Pavmed subsidiary, Veris Health and the Ohio State University Comprehensive Cancer Center launch commercial phase of strategic partnership agreement - MarketScreener
PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement - Stock Titan
What Fibonacci levels say about PAVmed Inc. rebound2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Why analysts upgrade PAVmed Inc. stockBreakout Watch & High Return Trade Guides - newser.com
Ascendiant Capital Maintains PAVmed (PAVM) Buy Recommendation - Nasdaq
PAVmed Inc Stock Analysis and ForecastREITs Market Trends & Small Budget Capital Growth - earlytimes.in
PAVM: Ascendiant Capital Raises Price Target with Continued 'Buy - GuruFocus
Key metrics from PAVmed Inc.’s quarterly data2025 Volatility Report & Intraday High Probability Alerts - newser.com
Will PAVmed Inc. stock recover faster than peersBreakout Watch & Verified High Yield Trade Plans - newser.com
Comparing PAVmed Inc. in custom built stock radarsTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
What data driven models say about PAVmed Inc.’s futureChart Signals & Consistent Profit Alerts - newser.com
Will PAVmed Inc. stock split again soonJuly 2025 PostEarnings & Verified Short-Term Plans - newser.com
Real time pattern detection on PAVmed Inc. stockQuarterly Earnings Summary & Real-Time Volume Analysis - newser.com
Transcript : PAVmed Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Pavmed Inc (PAVM) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):